Human Papillomavirus 16 E6 Antibodies in Individuals Without Diagnosed Cancer: A Pooled Analysis

BACKGROUND: The increasing incidence of oropharyngeal cancer in many developed countries has been attributed to human papillomavirus type 16 (HPV16) infections. Recently, HPV16 E6 serology has been identified as a promising early marker for oropharyngeal cancer. Therefore, characterization of HPV16...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Cancer Epidemiol Biomarkers Prev
المؤلفون الرئيسيون: Lang Kuhs, Krystle A., Anantharaman, Devasena, Waterboer, Tim, Johansson, Mattias, Brennan, Paul, Michel, Angelika, Willhauck-Fleckenstein, Martina, Purdue, Mark P., Holcátová, Ivana, Ahrens, Wolfgang, Lagiou, Pagona, Polesel, Jerry, Simonato, Lorenzo, Merletti, Franco, Healy, Claire M., Kjaerheim, Kristina, Conway, David I., Macfarlane, Tatiana V., Thomson, Peter, Castellsagué, Xavier, Znaor, Ariana, Black, Amanda, Huang, Wen-Yi, Krogh, Vittorio, Trichopoulou, Antonia, Bueno-de-Mesquita, H.B(as)., Clavel-Chapelon, Françoise, Weiderpass, Elisabete, Ekström, Johanna, Riboli, Elio, Tjønneland, Anne, Sánchez, María-José, Travis, Ruth C., Hildesheim, Allan, Pawlita, Michael, Kreimer, Aimée R.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2015
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4383678/
https://ncbi.nlm.nih.gov/pubmed/25623733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-14-1217
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة